Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02156687 · ClinicalTrials.gov registry record · NA

Randomized Trial of Y Mesh vs Dual Mesh

A NA study of Prolapse, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
59
Enrollment target
1
Study location

NCT02156687: Completed NA study of Prolapse, sponsored by The Cleveland Clinic.

NCT02156687 is a NA study of Prolapse that has completed, run by The Cleveland Clinic. The registered enrollment target is 59 participants, below the 230-participant average among 3 other Prolapse trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02156687, a NA study of Prolapse, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
59 participants
Enrollment target
1
Study location

Study Summary

The primary objective of the proposed study is to determine the difference in suturing time when using the restorelle Y mesh versus the restorelle dual flat mesh at the time of laparoscopic and robotic-assisted laparoscopic sacrocolpopexy. Hypothesis: Suturing time when using the restorelle Y mesh will be faster than when using the restorelle dual flat mesh at the time of laparoscopic and robotic-assisted laparoscopic sacrocolpopexy.

Conditions Studied

Interventions

  • DEVICE Y mesh
  • DEVICE Dual flat mesh

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2014-04-14
Est. Completion 2020-04-01
Phase NA
The Cleveland Clinic

688 total trials

What the finished NCT02156687 record still lists

NCT02156687 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 230-participant average among 3 other Prolapse trials with a reported enrollment target (74% lower).

The record links to 1 condition, with Prolapse appearing as the primary indexed condition, and to 2 interventions - of which Y mesh is the first listed.

NCT02156687 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT02156687 about?

NCT02156687 is a clinical study titled "Randomized Trial of Y Mesh vs Dual Mesh". The primary objective of the proposed study is to determine the difference in suturing time when using the restorelle Y mesh versus the restorelle dual flat mesh at the time of laparoscopic and robotic-assisted laparoscopic sacrocolpopexy. Hypothesis: Suturing time when using the restorelle Y mesh ...

What is the current status of trial NCT02156687?

This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2014-04-14. Estimated completion is 2020-04-01.

What conditions does trial NCT02156687 study?

This clinical trial studies the following conditions: Prolapse.

What interventions are being tested in trial NCT02156687?

The interventions under investigation include: Y mesh (DEVICE), Dual flat mesh (DEVICE).

Who is sponsoring clinical trial NCT02156687?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02156687 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prolapse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03801083 · 59 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers

  • NCT04332367 · 59 participants · Phase 2

    Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance

  • NCT05489575 · 59 participants · NA

    CPAP for the Treatment of Supine Hypertension

  • NCT06721689 · 59 participants · Phase 1

    PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02156687, the US trial registry maintained by the National Library of Medicine. NCT02156687 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.